Drugs Information: Copanlisib
Basic Information
|
||
| ID | DDInter441 | |
| Drug Type | small molecule | |
| Molecular Formula | C23H28N8O4 | |
| Molecular Weight | 480.529 | |
| Description | Copanlisib is a medication used to treat relapsed follicular lymphoma who have attempted at least two other treatments. | |
| ATC Classification | L01XX61 | |
| IUPAC Name | 2-Amino-N-{7-Methoxy-8-[3-(Morpholin-4-Yl)Propoxy]-2H,3H-Imidazo[1,2-C]Quinazolin-5-Yl}Pyrimidine-5-Carboxamide | |
| InChI | Inchi=1S/C23H28N8O4/C1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15/H3-4,13-14H,2,5-12H2,1H3,(H2,24,26,27)(H,28,29,32) | |
| InChI Key | PZBCKZWLPGJMAO-UHFFFAOYSA-N | |
| Canonical SMILES | COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21 | |
| Useful Links | DrugBank ChEMBL PubChem | |
Interactions with Copanlisib
| Severity level | ID | Name | Mechanism | Detail |
|---|